Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb 2;12(3):230-250.
doi: 10.18632/oncotarget.27870.

Cancer stem cells and macrophages: molecular connections and future perspectives against cancer

Affiliations
Review

Cancer stem cells and macrophages: molecular connections and future perspectives against cancer

Beatrice Aramini et al. Oncotarget. .

Abstract

Cancer stem cells (CSCs) have been considered the key drivers of cancer initiation and progression due to their unlimited self-renewal capacity and their ability to induce tumor formation. Macrophages, particularly tumor-associated macrophages (TAMs), establish a tumor microenvironment to protect and induce CSCs development and dissemination. Many studies in the past decade have been performed to understand the molecular mediators of CSCs and TAMs, and several studies have elucidated the complex crosstalk that occurs between these two cell types. The aim of this review is to define the complex crosstalk between these two cell types and to highlight potential future anti-cancer strategies.

Keywords: cancer; cancer stem cells; future perspectives; macrophages; target treatments.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST Authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1. Main roles of tumor associated macrophages in cancer development and manteinance.
TAMs and their released factors are involved in different processes controlling the evolution of cancer. Schematic representation of the role of TAMs in tumor growth, angiogenesis, invasion, metastasis and regulation of T lymphocytes.

References

    1. Ayob AZ, Ramasamy TS. Cancer stem cells as key drivers of tumour progression. J Biomed Sci. 2018; 25:20. 10.1186/s12929-018-0426-4. - DOI - PMC - PubMed
    1. Teng YD, Wang L, Kabatas S, Ulrich H, Zafonte RD. Cancer Stem Cells or Tumor Survival Cells? Stem Cells Dev. 2018; 27:1466– 78. 10.1089/scd.2018.0129. - DOI - PMC - PubMed
    1. Schulenburg A, Blatt K, Cerny-Reiterer S, Sadovnik I, Herrmann H, Marian B, Grunt TW, Zielinski CC, Valent P. Cancer stem cells in basic science and in translational oncology: can we translate into clinical application? J Hematol Oncol. 2015; 8:16. 10.1186/s13045-015-0113-9. - DOI - PMC - PubMed
    1. Aramini B, Masciale V, Haider KH. Defining lung cancer stem cells exosomal payload of miRNAs in clinical perspective. World J Stem Cells. 2020; 12:406–21. 10.4252/wjsc.v12.i6.406. - DOI - PMC - PubMed
    1. Masciale V, Grisendi G, Banchelli F, D’Amico R, Maiorana A, Sighinolfi P, Pinelli M, Lovati E, Stefani A, Morandi U, Dominici M, Aramini B. Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. Ann Transl Med. 2019; 7:619. 10.21037/atm.2019.11.27. - DOI - PMC - PubMed

LinkOut - more resources